Bayer, Google Cloud team up for early drug discovery
Ignatiev/E+ via Getty Images


Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) said on Wednesday that it is collaborating with Google Cloud for early drug discovery.
The collaboration will use Tensor Processing Units (TPUs) from Google Cloud, a unit of Alphabet (GOOG) (GOOGL), to help accelerate and scale Bayer's quantum chemistry calculations.

The German conglomerate said that the theory of quantum mechanics applied to computer-aided drug discovery enables the in-silico modeling of biological and chemical systems with high accuracy, and has the potential to help identify novel drug candidates.
The objectives of the partnership are to accelerate and scale quantum chemistry calculations using TPUs and to show fully quantum mechanical modeling of protein-ligand interactions.
The results will decide the scientific and economic viability of large-scale density functional theory calculations for practical applications, according to Bayer.
"By combining Google Cloudâs computing power with Bayerâs leading expertise in drug discovery we intend to unleash the potential of large-scale quantum chemistry," said Marianne De Backer, head of Strategy, Business Development & Licensing/Open Innovation and member of the Executive Committee, Pharmaceuticals Division at Bayer.